lamotrigine 10 MG/ML Oral Suspension [Subvenite]
- RxCUI
- 2724466
- RxNorm name
- lamotrigine 10 MG/ML Oral Suspension [Subvenite]
- Display name
- lamotrigine 10 MG/ML Oral Suspension [Subvenite]
- Full name
- lamotrigine 10 MG/ML Oral Suspension [Subvenite]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:45
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SUBVENITE | LAMOTRIGINE | OWP Pharmaceuticals, Inc. | 022b0913-f683-4af8-a862-f81b315909b2 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 2724466 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 022b0913-f683-4af8-a862-f81b315909b2 | Subvenite 10 MG/mL Oral Suspension [PSN] · lamotrigine 10 MG/ML Oral Suspension [Subvenite] [SBD] · Subvenite 10 MG/ML Oral Suspension [SY] | 3 | 2 | These highlights do not include all the information needed to use SUBVENITE ® safely and effectively. See full prescribing information for SUBVENITE ® . SUBVENITE (lamotrigine) oral suspension Initial U.S. Approval: 1994 | 20260116 |